Press Releases

Date Title
5/2/23 Sarepta Therapeutics Announces First Quarter 2023 Financial Results and Recent Corporate Developments
4/28/23 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/25/23 Sarepta Therapeutics to Announce First Quarter 2023 Financial Results
4/10/23 Sarepta Therapeutics Announces that the Date of the Advisory Committee Meeting for SRP-9001 will be May 12, 2023
3/31/23 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/16/23 Sarepta Therapeutics Announces Advisory Committee Meeting will be Held for SRP-9001
2/28/23 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/28/23 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments
2/28/23 Sarepta Therapeutics Announces Call for Applications for the 6th Annual Route 79, The Duchenne Scholarship Program
2/28/23 Sarepta Therapeutics anuncia convocatoria de solicitudes para el 6.º Route 79 anual, el programa de becas Duchenne
Displaying 41 - 50 of 813